Xcout Intel
Antares Therapeutics
Antares Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on developing first-in-class precision medicines.
Subscribe to see Antares Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Antares Therapeutics at a glance
Antares Therapeutics is a pharmaceuticals company headquartered in United States. Its most recent funding round raised $30M in May 2025. Xcout tracks 18 named people at Antares Therapeutics, including Adam Friedman (Chief Executive Officer). Xcout recorded 4 job postings from Antares Therapeutics in the last 90 days.
Antares Therapeutics leadership
- Adam FriedmanChief Executive Officer
- Amanda ValentinoChief People Officer
- Darrin StuartChief Development Officer
- Erica L. JacksonChief Scientific Officer
- Mark ChaoChief Medical Officer
- Andrew FedderGeneral Counsel
12 more named people on record for Antares Therapeutics, with roles, board committees and tenure — see the full roster →
Antares Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $30M | — | |
| Series A | $177M | 2 named | |
| SEC Form D filing | $40M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Antares Therapeutics
Xcout recorded 4 job postings from Antares Therapeutics in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Antares Therapeutics's hiring signals →
Investors
Antares Therapeutics competitors
A few of Antares Therapeutics's closest competitors — see the full list of competitors and alternatives →
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company headquartered in Waltham, Massachusetts. Founded in 2008, the public company discovers, develops, and commercializes targeted therapeutic treatments for autoimmune and inflammatory diseases.
Boston Pharmaceuticals is a U.S.-based clinical-stage biopharmaceutical company that acquires, develops, and advances drug candidates for serious diseases. It works with pharmaceutical and biotechnology partners to bring clinical-stage medicines toward commercialization and serves patients with significant unmet medical needs.
Slate Medicines is a privately held biotechnology company advancing next-generation therapeutics for headache treatment, with headquarters located in Raleigh, North Carolina and Boston, Massachusetts.
Sparrow Pharmaceuticals, Inc. is a Boston-based biopharmaceutical company focused on developing targeted cardiometabolic therapeutics. The company aims to address conditions such as diabetes and endocrine diseases with precision therapies.
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
Get Antares Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Antares Therapeutics in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access